Learn More
CD73 Mouse anti-Human, PE, Clone: AD2, BD
Mouse Monoclonal Antibody
81.32€ - 268.57€
Spécification
| Antigène | CD73 |
|---|---|
| Clone | AD2 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Conjugué | PE |
| Code produit | Marque | Quantité | Prix | Quantité et disponibilité | |||||
|---|---|---|---|---|---|---|---|---|---|
| Code produit | Marque | Quantité | Prix | Quantité et disponibilité | |||||
|
15820689
|
BD Biosciences
561014 |
25 Tests |
81.40€ 81.32€ / 1 pièce Économisez 0.08€ 0.10% de réduction |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | |||||
|
10470015
|
BD Biosciences
550257 |
100 Tests |
269.00€ 268.57€ / 1 pièce Économisez 0.43€ 0.16% de réduction |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | |||||
Description
The AD2 monoclonal antibody specifically binds to ecto-5’-nucleotidase, a 70 kDa, glycosyl phosphatidylinositol (GPI)-anchored glycoprotein. CD73 is expressed on subsets of T and B lymphocytes, follicular dendritic cells, epithelial cells, endothelial cells and mesenchymal stem cells. Its expression on lymphocytes increases during T and B cell development. CD73 has enzymatic activity and catalyzes the dephosphorylation of adenosine monophosphate (AMP) converting it to adenosine. It has been suggested that CD73 can mediate costimulatory signals in T cell activation and adhesion of lymphocytes to endothelium.
Spécification
| CD73 | |
| Flow Cytometry | |
| PE | |
| RUO | |
| Aqueous buffered solution containing BSA and ≤0.09% sodium azide. | |
| IgG1 κ | |
| Affinity Purified | |
| NT5E; 5' nucleotidase; 5'-NT; E5NT; Ecto-5'-nucleotidase; eN; eNT; NT; NT5 |
| AD2 | |
| Monoclonal | |
| Mouse | |
| Human | |
| Pre-B leukemia cell line | |
| Primary | |
| Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. |
For Research Use Only.
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.